SEIJI KITAGAWA to Biological Products
This is a "connection" page, showing publications SEIJI KITAGAWA has written about Biological Products.
Connection Strength
0.177
-
Infliximab Can Be Effective in Pediatric Patients with Ulcerative Colitis and Primary Failure of Adalimumab. Ann Clin Lab Sci. 2022 Sep; 52(5):796-801.
Score: 0.177
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.